DiNicolantonio, J. J., Barroso-Aranda, J., & McCarty, M. F. (2021). Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors. Open Heart.
Chicago Style aipamenaDiNicolantonio, James J., Jorge Barroso-Aranda, and Mark F. McCarty. "Anti-inflammatory Activity of Ivermectin in Late-stage COVID-19 May Reflect Activation of Systemic Glycine Receptors." Open Heart 2021.
MLA aipamenaDiNicolantonio, James J., Jorge Barroso-Aranda, and Mark F. McCarty. "Anti-inflammatory Activity of Ivermectin in Late-stage COVID-19 May Reflect Activation of Systemic Glycine Receptors." Open Heart 2021.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.